Lupin informs about transcript of conference call

25 May 2022 Evaluate

Pursuant to Regulation 30(2) read with Schedule Ill Part A Para A (15) (b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that it enclosed a copy of the Transcript of the Q4 FY2022 Investor Meet/ Earnings Conference Call held on Thursday, May 19, 2022.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2198.25 12.00 (0.55%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.